Region-specific contribution of the ventral tegmental area to heroin-induced conditioned immunomodulation

Brain, Behavior, and Immunity

Volumn 38, Issue , 2014, Pages 118-124

  Hutson, Lee W ^a   Szczytkowski, Jennifer L ^a   Saurer, Timothy B ^a   Lebonville, Christina ^a   Fuchs, Rita A ^a   Lysle, Donald T ^a  

^a University of North Carolina at Chapel Hill   (United States)

Author keywords

Conditioning; Heroin; Nitric oxide; TNF ; Ventral tegmental area

Indexed keywords

BACLOFEN; DIAMORPHINE; MUSCIMOL; NITRATE; NITRIC OXIDE; NITRITE; TUMOR NECROSIS FACTOR ALPHA; 4 AMINOBUTYRIC ACID; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR; IMMUNOLOGIC FACTOR; NARCOTIC AGENT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HISTOPATHOLOGY; IMMUNE RESPONSE; IMMUNOMODULATION; INNATE IMMUNITY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT; VENTRAL TEGMENTUM; ANTERIOR VENTRAL TEGMENTAL AREA; CONDITIONING; POSTERIOR VENTRAL TEGMENTAL AREA; ANIMAL; DRUG EFFECTS; IMMUNOLOGY; LEWIS RAT;

ANIMALS; CONDITIONING (PSYCHOLOGY); HEROIN; IMMUNOLOGIC FACTORS; IMMUNOMODULATION; LIPOPOLYSACCHARIDES; MALE; NARCOTICS; RATS; RATS, INBRED LEW; VENTRAL TEGMENTAL AREA;

EID: 84898548138     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2014.01.008     Document Type: Article

References (50)

1. Bossert J.M., Liu S.Y., Lu L., Shaham Y. A role of ventral tegmental area glutamate in contextual cue-induced relapse to heroin seeking. J. Neurosci. 2004, 24:10726-10730.
2. Bossert J.M., Stern A.L., Theberge F.R., Marchant N.J., Wang H.L., Morales M., Shaham Y. Role of projections from ventral medial prefrontal cortex to nucleus accumbens shell in context-induced reinstatement of heroin seeking. J. Neurosci. 2012, 32:4982-4991.
3. Bourdy R., Barrot M. A new control center for dopaminergic systems: pulling the VTA by the tail. Trends Neurosci. 2012, 35:681-690.
4. Broadbent J., Cunningham C.L. Pavlovian conditioning of morphine hyperthermia: assessment of interstimulus interval and CS-US overlap. Psychopharmacology 1996, 126:156-164.
5. Chao C., Molitor T., Close K., Hu S., Peterson P. Morphine inhibits the release of tumor necrosis factor in human peripheral blood mononuclear cell cultures. Int. J. Immunopharmacol. 1993, 15:447-453.
6. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 1987, 162:156-159.
7. Coussons M.E., Dykstra L.A., Lysle D.T. Pavlovian conditioning of morphine-induced alterations of immune status. J. Neuroimmunol. 1992, 39:219-230.
8. Daglish M.R., Weinstein A., Malizia A.L., Wilson S., Melichar J.K., Britten S., Brewer C., Lingford-Hughes A., Myles J.S., Grasby P., Nutt D.J. Changes in regional cerebral blood flow elicited by craving memories in abstinent opiate-dependent subjects. Am. J. Psychiatry 2001, 158:1680-1686.
9. Fecho K., Lysle D.T. Heroin-induced alterations in leukocyte numbers and apoptosis in the rat spleen. Cell. Immunol. 2000, 202:113-123.
10. Fecho K., Maslonek K.A., Dykstra L.A., Lysle D.T. Assessment of the involvement of central nervous system and peripheral opioid receptors in the immunomodulatory effects of acute morphine treatment in rats. J. Pharmacol. Exp. Ther. 1996, 276:626-636.
11. Ford C., Mark G., Williams J. Properties and opioid inhibition of mesolimbic dopamine neurons vary according to target location. J. Neurosci. 2006, 26:2788-2797.
12. Fuchs R.A., See R.E. Basolateral amygdala inactivation abolishes conditioned stimulus- and heroin-induced reinstatement of extinguished heroin-seeking behavior in rats. Psychopharmacology 2002, 160:425-433.
13. Fujihara M., Muroi M., Tanamoto K., Suzuki T., Azuma H., Ikeda H. Molecular mechanisms of macrophage activation and deactivation by lipopolysaccharide: roles of the receptor complex. Pharmacol. Ther. 2003, 100:171-194.
14. Govitrapong P., Suttitum T., Kotchabhakdi N., Uneklabh T. Alterations of immune functions in heroin addicts and heroin withdrawal subjects. J. Pharmacol. Exp. Ther. 1998, 286:883-889.
15. Howland J., Taepavarapruk P., Phillips A. Glutamate receptor-dependent modulation of dopamine efflux in the nucleus accumbens by basolateral, but not central, nucleus of the amygdala in rats. J. Neurosci. 2002, 22:1137-1145.
16. Hsueh C.M., Kuo J.S., Chen S.F., Huang H.J., Cheng F.C., Chung L.J., Lin R.J. Involvement of catecholamines in recall of the conditioned NK cell response. J. Neuroimmunol. 1999, 94:172-181.
17. Ikemoto S. Dopamine reward circuitry: two projection systems from the ventral midbrain to the nucleus accumbens-olfactory tubercle complex. Brain Res Rev 2007, 56:27-78.
18. Ikemoto S., Kohl R., McBride W. GABA(A) receptor blockade in the anterior ventral tegmental area increases extracellular levels of dopamine in the nucleus accumbens of rats. J Neurochem. 1997, 69:137-143.
19. Ikemoto S., Murphy J., McBride W. Self-infusion of GABA(A) antagonists directly into the ventral tegmental area and adjacent regions. Behav. Neurosci. 1997, 111:369-380.
20. Johnson S.W., North R.A. Opioids excite dopamine neurons by hyperpolarization of local interneurons. J Neurosci 1992, 12:483-488.
21. Johnson S.W., North R.A. Two types of neurone in the rat ventral tegmental area and their synaptic inputs. J. Physiol. 1992, 450:455-468.
22. Jones J., Day J., Aragona B., Wheeler R., Wightman R., Carelli R. Basolateral amygdala modulates terminal dopamine release in the nucleus accumbens and conditioned responding. Biol. Psychiatry 2010, 67:737-744.
23. Kiyatkin E., Rebec G. Impulse activity of ventral tegmental area neurons during heroin self-administration in rats. Neuroscience 2001, 102:565-580.
24. Kuo J.S., Chen S.F., Huang H.J., Yang C.S., Tsai P.J., Hsueh C.M. The involvement of glutamate in recall of the conditioned NK cell response. J. Neuroimmunol. 2001, 118:245-255.
25. Lee D., Guttilla M., Fung K., McFeron S., Yan J., Ranaldi R. Rostral-caudal differences in the effects of intra-VTA muscimol on cocaine self-administration. Pharmacol. Biochem. Behav. 2007, 86:542-549.
26. Luo A.H., Tahsili-Fahadan P., Wise R.A., Lupica C.R., Aston-Jones G. Linking context with reward: a functional circuit from hippocampal CA3 to ventral tegmental area. Science 2011, 333:353-357.
27. Lysle D.T., Hoffman K.E., Dykstra L.A. Evidence for the involvement of the caudal region of the periaqueductal gray in a subset of morphine-induced alterations of immune status. J. Pharmacol. Exp. Ther. 1996, 277:1533-1540.
28. Lysle D.T., How T. Heroin modulates the expression of inducible nitric oxide synthase. Immunopharmacology 2000, 46:181-192.
29. Lysle D.T., Ijames S.G. Heroin-associated environmental stimuli modulate the expression of inducible nitric oxide synthase in the rat. Psychopharmacology 2002, 164:416-422.
30. Nair N.K., Navaratnam V., Rajananda V. Analysis of illicit heroin. I. An effective thin-layer chromatographic system for separating eight opiates and five adulterants. J. Chromatogr. 1986, 366:363-372.
31. Olson V., Zabetian C., Bolanos C., Edwards S., Barrot M., Eisch A., Hughes T., Self D., Neve R., Nestler E. Regulation of drug reward by cAMP response element-binding protein: evidence for two functionally distinct subregions of the ventral tegmental area. J. Neurosci. 2005, 25:5553-5562.
32. Pacifici R., di Carlo S., Bacosi A., Pichini S., Zuccaro P. Pharmacokinetics and cytokine production in heroin and morphine-treated mice. Int. J. Immunopharmacol. 2000, 22:603-614.
33. Rosenkranz J.A., Grace A.A. Modulation of basolateral amygdala neuronal firing and afferent drive by dopamine receptor activation in vivo. J. Neurosci. 1999, 19:11027-11039.
34. Saurer T., Ijames S., Carrigan K., Lysle D. Neuroimmune mechanisms of opioid-mediated conditioned immunomodulation. Brain Behav. Immun. 2008, 22:89-97.
35. Saurer T.B., James S.G., Carrigan K.A., Lysle D.T. Neuroimmune mechanisms of opioid-mediated conditioned immunomodulation. Brain Behav. Immun. 2008, 22:89-97.
36. Schwarz-Stevens K.S., Cunningham C.L. Pavlovian conditioning of heart rate and body temperature with morphine: effects of CS duration. Behav. Neurosci. 1993, 107:1039-1048.
37. Schwarz K.S., Cunningham C.L. Conditioned stimulus control of morphine hyperthermia. Psychopharmacology 1990, 101:77-84.
38. Sell L.A., Morris J.S., Bearn J., Frackowiak R.S., Friston K.J., Dolan R.J. Neural responses associated with cue evoked emotional states and heroin in opiate addicts. Drug Alcohol Depend. 2000, 60:207-216.
39. Shavit Y., Depaulis A., Martin F.C., Terman G.W., Pechnick R.N., Zane C.J., Gale R.P., Liebeskind J.C. Involvement of brain opiate receptors in the immune-suppressive effect of morphine. Proc. Natl. Acad. Sci. U. S. A. 1986, 83:7114-7117.
40. Soderman A., Unterwald E. Cocaine reward and hyperactivity in the rat: sites of mu opioid receptor modulation. Neuroscience 2008, 154:1506-1516.
41. Swanson L.W. The projections of the ventral tegmental area and adjacent regions: a combined fluorescent retrograde tracer and immunofluorescence study in the rat. Brain Res. Bull. 1982, 9:321-353.
42. Szczytkowski J.L., Fuchs R.A., Lysle D.T. Ventral tegmental area-basolateral amygdala-nucleus accumbens shell neurocircuitry controls the expression of heroin-conditioned immunomodulation. J. Neuroimmunol. 2011, 237:47-56.
43. Szczytkowski J.L., Lebonville C., Hutson L., Fuchs R.A., Lysle D.T. Heroin-induced conditioned immunomodulation requires expression of IL-1beta in the dorsal hippocampus. Brain Behav. Immun. 2013, 30:95-102.
44. Szczytkowski J.L., Lysle D.T. Conditioned effects of heroin on the expression of inducible nitric oxide synthase in the rat are susceptible to extinction and latent inhibition. Psychopharmacology 2007, 191:879-889.
45. Szczytkowski J.L., Lysle D.T. Conditioned effects of heroin on proinflammatory mediators require the basolateral amygdala. Eur. J. Neurosci. 2008, 28:1867-1876.
46. Szczytkowski J.L., Lysle D.T. Dopamine D1 receptors within the basolateral amygdala mediate heroin-induced conditioned immunomodulation. J. Neuroimmunol. 2010, 226:38-47.
47. Theodorou S., Haber P.S. The medical complications of heroin use. Curr. Opini. Psychiatry 2005, 18:257-263.
48. Yamaguchi T., Sheen W., Morales M. Glutamatergic neurons are present in the rat ventral tegmental area. Eur. J. Neurosci. 2007, 25:106-118.
49. Yardeni I.Z., Beilin B., Mayburd E., Alcalay Y., Bessler H. Relationship between fentanyl dosage and immune function in the postoperative period. J. Opioid Manag. 2008, 4:27-33.
50. Zijlstra F., Veltman D.J., Booij J., van den Brink W., Franken I.H. Neurobiological substrates of cue-elicited craving and anhedonia in recently abstinent opioid-dependent males. Drug Alcohol Depend. 2009, 99:183-192.